Courier Capital LLC grew its position in shares of The Clorox Company (NYSE:CLX – Free Report) by 4.2% during the 4th quarter, according to the company in its most recent disclosure with the SEC. The fund owned 2,495 shares of the company’s stock after purchasing an additional 100 shares during the quarter. Courier Capital LLC’s holdings in Clorox were worth $405,000 as of its most recent filing with the SEC.
Several other institutional investors and hedge funds have also made changes to their positions in CLX. Prospera Private Wealth LLC purchased a new position in Clorox during the 3rd quarter worth approximately $27,000. Continuum Advisory LLC grew its position in shares of Clorox by 300.0% during the third quarter. Continuum Advisory LLC now owns 184 shares of the company’s stock worth $30,000 after acquiring an additional 138 shares during the last quarter. Quarry LP increased its holdings in shares of Clorox by 99.1% in the 2nd quarter. Quarry LP now owns 229 shares of the company’s stock valued at $31,000 after acquiring an additional 114 shares during the period. Carolina Wealth Advisors LLC purchased a new stake in Clorox in the 3rd quarter valued at $48,000. Finally, Friedenthal Financial acquired a new stake in Clorox during the 3rd quarter worth $49,000. 78.53% of the stock is owned by hedge funds and other institutional investors.
Analysts Set New Price Targets
A number of research analysts have commented on CLX shares. DA Davidson lifted their price objective on shares of Clorox from $153.00 to $171.00 and gave the company a “neutral” rating in a research note on Monday, November 4th. StockNews.com downgraded Clorox from a “buy” rating to a “hold” rating in a research note on Sunday, January 5th. Jefferies Financial Group raised Clorox from a “hold” rating to a “buy” rating and boosted their target price for the company from $174.00 to $187.00 in a report on Tuesday, October 1st. Evercore ISI decreased their price target on Clorox from $140.00 to $139.00 and set an “underperform” rating for the company in a report on Monday, October 14th. Finally, TD Cowen raised shares of Clorox from a “sell” rating to a “hold” rating and boosted their price objective for the company from $155.00 to $170.00 in a research note on Wednesday, November 6th. Four research analysts have rated the stock with a sell rating, ten have given a hold rating and one has given a buy rating to the stock. According to data from MarketBeat, the stock has a consensus rating of “Hold” and an average price target of $157.46.
Clorox Price Performance
CLX stock opened at $157.32 on Tuesday. The company has a market cap of $19.47 billion, a price-to-earnings ratio of 54.82, a PEG ratio of 3.04 and a beta of 0.42. The company has a current ratio of 1.00, a quick ratio of 0.62 and a debt-to-equity ratio of 11.08. The firm has a 50 day moving average of $164.55 and a 200-day moving average of $156.00. The Clorox Company has a 12-month low of $127.60 and a 12-month high of $171.37.
Clorox (NYSE:CLX – Get Free Report) last posted its earnings results on Wednesday, October 30th. The company reported $1.86 EPS for the quarter, topping analysts’ consensus estimates of $1.36 by $0.50. Clorox had a return on equity of 316.08% and a net margin of 4.78%. The company had revenue of $1.76 billion for the quarter, compared to the consensus estimate of $1.64 billion. During the same period in the previous year, the business earned $0.49 earnings per share. Clorox’s quarterly revenue was up 27.0% compared to the same quarter last year. As a group, equities analysts expect that The Clorox Company will post 6.85 EPS for the current fiscal year.
Clorox Announces Dividend
The firm also recently announced a quarterly dividend, which will be paid on Friday, February 14th. Shareholders of record on Wednesday, January 29th will be given a dividend of $1.22 per share. This represents a $4.88 dividend on an annualized basis and a yield of 3.10%. The ex-dividend date of this dividend is Wednesday, January 29th. Clorox’s payout ratio is currently 170.03%.
About Clorox
The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.
Featured Articles
- Five stocks we like better than Clorox
- Financial Services Stocks Investing
- 2 Stocks to Gain From Trump Universal Tariffs on Critical Imports
- How Technical Indicators Can Help You Find Oversold Stocks
- Rigetti Computing, Inc.: Buy, Sell, or Hold for 2025
- The 3 Best Fintech Stocks to Buy Now
- Delta Can Fly to New Highs in 2025; Here’s Why
Receive News & Ratings for Clorox Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Clorox and related companies with MarketBeat.com's FREE daily email newsletter.